InMed Pharmaceuticals (INM) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free INM Stock Alerts $0.27 0.00 (-1.46%) (As of 10:09 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | theglobeandmail.comInMed (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMDMarch 23, 2024 | theglobeandmail.comInMed Pharmaceuticals (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day ExtensionFebruary 10, 2024 | markets.businessinsider.comInMed Pharmaceuticals Welcomes New CFO Neeta JagpalFebruary 10, 2024 | msn.comInMed Pharmaceuticals Announces New CFO AppointmentFebruary 9, 2024 | finance.yahoo.comInMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial OfficerJanuary 25, 2024 | benzinga.comInMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet NeedJanuary 18, 2024 | finance.yahoo.comInMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ETDecember 20, 2023 | finanznachrichten.deInMed Pharmaceuticals: InMed Announces Results of 2023 Annual General MeetingDecember 19, 2023 | finance.yahoo.comInMed Announces Results of 2023 Annual General MeetingNovember 14, 2023 | finance.yahoo.comInMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business UpdateNovember 8, 2023 | msn.comInMed Pharmaceuticals files to sell 12.57M shares for holdersNovember 8, 2023 | morningstar.comInMed Pharmaceuticals Inc INMNovember 2, 2023 | finance.yahoo.comInMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023October 27, 2023 | finance.yahoo.comInMed Pharmaceuticals Announces the Closing of $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq RulesOctober 25, 2023 | investorplace.comWhy Is InMed Pharmaceuticals (INM) Stock Down 25% Today?October 24, 2023 | msn.comInMed Pharmaceuticals to raise $5.2M via private placementOctober 24, 2023 | finance.yahoo.comInMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq RulesOctober 24, 2023 | benzinga.comDow Surges 250 Points; US Manufacturing PMI Tops ExpectationsOctober 24, 2023 | benzinga.comWhy InMed Pharmaceuticals Stock Is Soaring TuesdayOctober 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 10:10 AM with a stated reason of "LULD pause." Trading set to resume at 10:10 AM. October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 3, 2023 | theglobeandmail.comInMed Pharmaceuticals (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate UpdateSeptember 29, 2023 | finance.yahoo.comInMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business UpdateSeptember 15, 2023 | benzinga.comThis Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness SectorSeptember 7, 2023 | finance.yahoo.comInMed to Present at H.C. Wainwright 25th Annual Global Investment ConferenceJuly 22, 2023 | au.finance.yahoo.comINM - InMed Pharmaceuticals Inc.July 21, 2023 | finance.yahoo.comInMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ETJune 22, 2023 | msn.comWhy Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 22, 2023 | finance.yahoo.comWhy Are InMed Pharmaceuticals Stock Trading Lower TodayJune 22, 2023 | finance.yahoo.comInMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis BullosaJune 1, 2023 | msn.comStudy Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's TreatmentJune 1, 2023 | finanznachrichten.deInMed Pharmaceuticals: InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience MeetingJune 1, 2023 | finance.yahoo.comInMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience MeetingMay 24, 2023 | finance.yahoo.comInMed to Participate in Upcoming Virtual Investor EventsMay 18, 2023 | finance.yahoo.comInMed to Participate in Fireside Chat with Water Tower Research on May 23, 2023 at 1pm ETMay 15, 2023 | seekingalpha.comInMed Pharmaceuticals GAAP EPS of -$0.60, revenue of $1.03MMay 15, 2023 | finance.yahoo.comInMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business UpdateApril 21, 2023 | marketwatch.comBiosynthesis of Cannabinoids Market Size: Growth Dynamics from 2023 to 2030March 30, 2023 | marketwatch.com2023-2029 Bed Head Panel Market Size and Industrial Analysis with Key Developments | Latest Report by Absolute ReportsMarch 28, 2023 | finance.yahoo.comInMed Announces Conclusion of Patient Enrollment in Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis BullosaMarch 20, 2023 | marketwatch.comSpasticity Treatment Market Growth and Forecast till 2029March 13, 2023 | msn.comRare Cannabinoids Could Help Treat Atopic Dermatitis, Psoriasis, Pruritus And Acne: New StudyMarch 7, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference on March 8 Register NowMarch 6, 2023 | finance.yahoo.comInMed to Participate in Upcoming Investor EventsFebruary 24, 2023 | marketwatch.comBiosynthesis of Canabinoids Market International Business Analysis, Development Outlook and Regional Strategies 2028January 11, 2023 | benzinga.comThis Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer'sJanuary 2, 2023 | marketwatch.comBiosynthesis of Cannabinoids Market Size and Share Likely to Grow with CAGR Status and Industry Revenue Forecast by 2023-2029December 15, 2022 | finance.yahoo.comInMed Announces Results of 2022 Annual General Meeting Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address WATCH: The Truth About Inflation (Ad)The full story on inflation is being CENSORED by the powers that be. But I have the REAL monthly numbers. And they are going to anger you. (Especially if you have money sitting in a 401k or IRA.) WATCH: The Truth About Inflation INM Media Mentions By Week INM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INM News Sentiment▼-0.100.55▲Average Medical News Sentiment INM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INM Articles This Week▼30▲INM Articles Average Week Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATNF News PRFX News NBSE News ALLR News QLGN News PXMD News LSDI News PBLA News BDRX News GRI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INM) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
